{"id":69554,"date":"2026-07-08T13:35:45","date_gmt":"2026-07-08T05:35:45","guid":{"rendered":"https:\/\/flcube.com\/?p=69554"},"modified":"2026-07-08T13:35:46","modified_gmt":"2026-07-08T05:35:46","slug":"china-adds-methoxyethyl-etomidate-loretomidate-and-solriamfetol-to-controlled-psychotropic-substances-list","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=69554","title":{"rendered":"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China&#8217;s <strong>National Medical Products Administration (NMPA)<\/strong>, in coordination with the <strong>Ministry of Public Security<\/strong> and the <strong>National Health Commission<\/strong>, announced the addition of three compounds\u2014<strong>methoxyethyl etomidate<\/strong>, <strong>loretomidate<\/strong>, and <strong>solriamfetol<\/strong>\u2014to the <strong>List of Medicinal Psychotropic Substances<\/strong>, effective <strong>1 October 2026<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-regulatory-action-summary\" class=\"wp-block-heading\">Regulatory Action Summary<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Agencies<\/strong><\/td><td>NMPA, Ministry of Public Security, National Health Commission<\/td><\/tr><tr><td><strong>Action<\/strong><\/td><td>Addition to List of Medicinal Psychotropic Substances<\/td><\/tr><tr><td><strong>Substances Added<\/strong><\/td><td>Methoxyethyl etomidate, Loretomidate, Solriamfetol<\/td><\/tr><tr><td><strong>Effective Date<\/strong><\/td><td>1 October 2026<\/td><\/tr><tr><td><strong>Legal Basis<\/strong><\/td><td>Regulations on Narcotic Drugs and Psychotropic Substances<\/td><\/tr><tr><td><strong>Exemptions<\/strong><\/td><td>Pharmaceutical preparations containing methoxyethyl etomidate or loretomidate already approved for marketing in China<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-substance-profiles-amp-clinical-context\" class=\"wp-block-heading\">Substance Profiles &amp; Clinical Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Methoxyethyl etomidate<\/strong>: A short-acting intravenous anesthetic agent derived from etomidate, used primarily for procedural sedation and induction of anesthesia.<\/li>\n\n\n\n<li><strong>Loretomidate<\/strong>: A structural analog of etomidate developed as a potential alternative with modified pharmacokinetic properties and potentially reduced adrenocortical suppression.<\/li>\n\n\n\n<li><strong>Solriamfetol<\/strong>: A dopamine and norepinephrine reuptake inhibitor approved in some markets for the treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The regulatory bodies cited concerns about potential misuse, diversion, and public health implications as key factors driving the classification decision. The move aligns China&#8217;s controlled substances framework with international monitoring practices for these compounds.<\/p>\n\n\n\n<h2 id=\"h-implementation-timeline-amp-industry-impact\" class=\"wp-block-heading\">Implementation Timeline &amp; Industry Impact<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pharmaceutical manufacturers and distributors will have until <strong>30 September 2026<\/strong> to adjust their compliance protocols, inventory management systems, and prescription verification processes to accommodate the new classification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Companies holding marketing authorization for products containing <strong>methoxyethyl etomidate<\/strong> or <strong>loretomidate<\/strong> are exempt from the new restrictions, ensuring continuity of care for patients currently using these approved formulations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Healthcare providers will need to update their prescribing practices for any non-exempt formulations containing these substances after the effective date, implementing stricter documentation and dispensing requirements consistent with other Schedule II psychotropic medications in China.<\/p>\n\n\n\n<h2 id=\"h-market-implications\" class=\"wp-block-heading\">Market Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Supply Chain<\/strong>: Distributors must implement enhanced tracking and security measures for these substances beginning 1 October 2026.<\/li>\n\n\n\n<li><strong>Research Sector<\/strong>: Academic and clinical researchers will face additional regulatory hurdles when seeking approval for studies involving these compounds.<\/li>\n\n\n\n<li><strong>International Alignment<\/strong>: The decision reflects China&#8217;s ongoing efforts to harmonize its controlled substances regulations with international standards, particularly those established by the International Narcotics Control Board.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains information regarding regulatory actions by Chinese authorities. Actual implementation may be subject to further guidance or administrative interpretations issued by the relevant agencies prior to the effective date.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[4],"tags":[60,14],"class_list":["post-69554","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nhc-nhfpc","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the National Health Commission, announced the addition of three compounds\u2014methoxyethyl etomidate, loretomidate, and solriamfetol\u2014to the List of Medicinal Psychotropic Substances, effective 1 October 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=69554\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the National Health Commission, announced the addition of three compounds\u2014methoxyethyl etomidate, loretomidate, and solriamfetol\u2014to the List of Medicinal Psychotropic Substances, effective 1 October 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=69554\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-08T05:35:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-08T05:35:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69554#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69554\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List\",\"datePublished\":\"2026-07-08T05:35:45+00:00\",\"dateModified\":\"2026-07-08T05:35:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69554\"},\"wordCount\":404,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NHC (NHFPC)\",\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69554#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69554\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=69554\",\"name\":\"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-07-08T05:35:45+00:00\",\"dateModified\":\"2026-07-08T05:35:46+00:00\",\"description\":\"China's National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the National Health Commission, announced the addition of three compounds\u2014methoxyethyl etomidate, loretomidate, and solriamfetol\u2014to the List of Medicinal Psychotropic Substances, effective 1 October 2026.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69554#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69554\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69554#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the National Health Commission, announced the addition of three compounds\u2014methoxyethyl etomidate, loretomidate, and solriamfetol\u2014to the List of Medicinal Psychotropic Substances, effective 1 October 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=69554","og_locale":"en_US","og_type":"article","og_title":"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List","og_description":"China's National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the National Health Commission, announced the addition of three compounds\u2014methoxyethyl etomidate, loretomidate, and solriamfetol\u2014to the List of Medicinal Psychotropic Substances, effective 1 October 2026.","og_url":"https:\/\/flcube.com\/?p=69554","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-07-08T05:35:45+00:00","article_modified_time":"2026-07-08T05:35:46+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=69554#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=69554"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List","datePublished":"2026-07-08T05:35:45+00:00","dateModified":"2026-07-08T05:35:46+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=69554"},"wordCount":404,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NHC (NHFPC)","NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=69554#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=69554","url":"https:\/\/flcube.com\/?p=69554","name":"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-07-08T05:35:45+00:00","dateModified":"2026-07-08T05:35:46+00:00","description":"China's National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the National Health Commission, announced the addition of three compounds\u2014methoxyethyl etomidate, loretomidate, and solriamfetol\u2014to the List of Medicinal Psychotropic Substances, effective 1 October 2026.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=69554#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=69554"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=69554#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=69554"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69554\/revisions"}],"predecessor-version":[{"id":69562,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69554\/revisions\/69562"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=69554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=69554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=69554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}